Human Reproduction, Vol. 16, No. 8, 1663-1670,
August 2001
© 2001 European Society of Human Reproduction and Embryology
Utero-ovarian blood flow characteristics of pituitary desensitization
1 Assisted Conception Unit and 2 Department of Research and Development, St James's University Hospital, Leeds, UK
BACKGROUND: Down-regulation in assisted reproduction treatment cycles is monitored by suppression of ovarian/pituitary hormones and/or measurement of endometrial thickness. METHODS: This prospective longitudinal study reports on utero-ovarian characteristics of pituitary desensitization. A total of 75 patients were recruited; 32 had IVF treatment, 20 frozen–thawed embryo transfer cycles and 23 patients were recipients of donated oocytes. All received early follicular-phase down-regulation and had colour flow Doppler velocimetry of the utero-ovarian arteries 
3 days before the start of menses and after 21 days of gonadotrophin-releasing hormone (GnRH) analogue treatment. Ovarian volume, endometrial thickness, pituitary and ovarian hormone concentrations were recorded at each scan. RESULTS: Significant changes (P < 0.05) were noted in these and utero-ovarian vasculature during the down-regulation period, with good correlation between resistance index and oestradiol estimations. Neither the type of GnRH analogue nor age influenced the changes in utero-ovarian blood flow. Ovarian artery resistance index was the best Doppler predictor for pituitary suppression and a mean discriminatory cut-off value of 0.867 ± 0.025 was found to have the highest specificity and positive predictive value. CONCLUSIONS: This study has, for the first time, defined cut-off values for satisfactory pituitary suppression with high positive predictive value and specificity in an early follicular phase long protocol of GnRH analogue down-regulation using colour flow Doppler.
Key words: assisted reproduction/Doppler ultrasound/pituitary desensitization/utero-ovarian blood flow
3 To whom correspondence should be addressed at: Assisted Conception Unit, St James's University Hospital, Leeds LS9 7TF, UK. E-mail: Babs{at}tdada.freeserve.co.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. L Meistrich and G. Shetty Hormonal suppression for fertility preservation in males and females Reproduction, December 1, 2008; 136(6): 691 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Beck-Fruchter, A. Weiss, and E. Shalev GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data Hum. Reprod. Update, November 1, 2008; 14(6): 553 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Meirow, J. Dor, B. Kaufman, A. Shrim, J. Rabinovici, E. Schiff, H. Raanani, J. Levron, and E. Fridman Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury Hum. Reprod., June 1, 2007; 22(6): 1626 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Yu Ng, C. Chi Wai Chan, O. S. Tang, W. Shu Biu Yeung, and P. Chung Ho Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation Hum. Reprod., December 1, 2004; 19(12): 2811 - 2815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Meirow, G. Assad, J. Dor, and J. Rabinovici The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice Hum. Reprod., June 1, 2004; 19(6): 1294 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dada and V. Sharma Ovarian artery resistance index as a marker of pituitary suppression Hum. Reprod., March 1, 2002; 17(3): 841 - 842. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Dickey and R. Pyrzak Ovarian artery resistance index as a marker of pituitary suppression Hum. Reprod., February 1, 2002; 17(2): 523 - 523. [Full Text] [PDF]
|
|